JPRN-UMIN000010052已完成2 期
Effect of edaravone against consciousness impairment after encephalitis - Effect of edaravone against consciousness impairment after encephalitis
niversity of Tsukuba0 个研究点目标入组 10 人开始时间: 2013年2月15日最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 16years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.male:Cre<1.3 mg/dl Female:Cre<1.0 mg/dl male & femaile:AST/ALT<more than three times the reference value 2.sepsis 3.epilepticus and severe coma 4.bacterial meningitis and encephalitis 5.DIC 6.allergy for edaravone 7. edaravone is used within two weeks prior to registration 8.acute cereberal infarction 9.Patients within 6 months after the end of the other trial 10.investigator has determined the patient disqualified as a target
研究者
相似试验
尚未招募
3 期
Effectivnes of edaravone on ischemic strokeIschemic stroke.Cerebral infarctionIRCT20240224061102N1Yasouj University of Medical Sciences60
招募中
1 期
Effects of edaravone on early postoperative cognitive function in elderly patients undergoing hip joint replacement surgeryPostoperative cognitive dysfunctionITMCTR1900002523Shanghai Pudong Hospital
已完成
3 期
Edaravone in COVID-19IRCT20200317046797N6Tabriz University of Medical Sciences30
招募中
3 期
Efficacy of Edaravone with Thrombolysis in Acute Ischemic StrokeIRCT20210530051440N1Zanjan University of Medical Sciences244
已完成
不适用
Clinical study of the effectiveness of edaravone for the oxidative stress in amyotrophic lateral sclerosisAmyotrophic Lateral Sclerosis (ALS)JPRN-UMIN000024854Okayama university20